Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 71, n° 1
pages 133-140 (juillet 2014)
Doi : 10.1016/j.jaad.2014.02.012
accepted : 6 February 2014
Reviews

Diet and psoriasis, part I: Impact of weight loss interventions
 

Maya Debbaneh, BA a, b, , Jillian W. Millsop, MD a, c, Bhavnit K. Bhatia, BA a, d, John Koo, MD a, Wilson Liao, MD a
a Department of Dermatology, University of California, San Francisco, California 
b University of California, Irvine, School of Medicine, Irvine, California 
c University of Utah School of Medicine, Salt Lake City, Utah 
d Rush Medical College, Rush University Medical Center, Chicago, Illinois 

Reprint requests: Maya Debbaneh, BA, Department of Dermatology, University of California, San Francisco, 515 Spruce St, San Francisco, CA 94118.

Please see the August and September issues for the second and third parts of this series .

Abstract

One of the most frequently asked questions by patients with psoriasis is whether dietary changes can improve their condition. Included in this discussion is whether dietary weight loss can benefit their skin disease. Obesity has been associated with a proinflammatory state and several studies have demonstrated a relationship between body mass index and psoriasis severity. However, the question of whether weight loss interventions can impact psoriasis outcome is less clear. Here, we review the literature to examine the efficacy of weight loss interventions, both dietary and surgical, on psoriasis disease course.

The full text of this article is available in PDF format.

Key words : body mass index, diet, gastric bypass, nutrition, obesity, psoriasis, weight loss

Abbreviations used : BMI, IL, MCP, MDA, PASI, PASI 75, TNF



 Dr Liao is supported in parts by grants from National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR065174, K08AR057763). There were no direct funding sources for this work.
 Disclosure: Dr Koo is a speaker for AbbVie and Leo. Dr Koo conducts research for Amgen, Janssen, Novartis, Photomedex, Galderma, Pfizer, and Merck. Dr Koo has no stocks, employment, or board memberships with any pharmaceutical company. None of the grants were directly related to this study. Ms Debbaneh, Dr Millsop, Ms Bhatia, and Dr Liao have no conflicts of interest to declare.
 Ms Debbaneh, Dr Millsop, and Ms Bhatia contributed equally to this work.



© 2014  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline